Investor Relations Home

Webcast ImageWebcast
Q2 2014 Masimo Corporation Earnings Conference Call (Live)
08/07/14 at 1:30 p.m. PT
2011 Annual Report
2012 Annual Report
2011 Annual Report
2011 Annual Report
2009 Annual Report
2009 Annual Report
2008 Annual Report
2008 Annual Report
2007 Annual Report
2007 Annual Report
   
Stock Quote
MASI (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$24.41
Change (%) Stock is Up 0.29 (1.20%)
Volume270,300
Data as of 07/23/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Online Investor Kit
Masimo Reports First Quarter 2014 Financial Results
2013 Form 10K
2014 Proxy Statement
2012 Annual Report
Corporate Profile

We are a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products that improve patient care. We were incorporated in California in May 1989 and reincorporated in Delaware in May 1996. We invented Masimo Signal Extraction Technology, or Masimo SET, which provides the capabilities of Measure-Through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. Pulse oximetry is the noninva... More >>

Upcoming EventsMore >>
DateTitleAdd to Calendar HelpRemind MePrior to Event
08/07/14 1:30 p.m. PTQ2 2014 Masimo Corporation Earnings Conference CallAdd Q2 2014 Masimo Corporation Earnings Conference Call to Calendar days
Enter your e-mail address 
Recent News
RSS Feeds RSS
| More >>
Masimo to Report Second Quarter 2014 Financial Results After Market Close on Thursday, August 7th - 07/21/14
Conference Call and Webcast to Begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, CA -- (Marketwired) -- 07/21/14 -- Masimo (NASDAQ: MASI) announced today that it will release financial results for the second quarter ended June 28, 2014, after the marke... More >>
New Study Evaluates Trending Accuracy and Reliability of Masimo's Continuous and Noninvasive SpHb(R) Technology - 07/09/14
TOKYO, JAPAN -- (Marketwired) -- 07/09/14 -- Masimo (NASDAQ: MASI) announced today that a new clinical study published in the Journal of Clinical Monitoring evaluated the relative trending accuracy of Masimo's noninvasive and continuous total hemog... More >>
Masimo Announces FDA Clearance of Root (TM) Patient Monitoring Platform With Capnography, IRIS(TM) Standalone Device Connectivity, and MOC-9(TM) Third-Party Measurement Expansion - 06/30/14
IRVINE, CA -- (Marketwired) -- 06/30/14 -- Masimo (NASDAQ: MASI) today announced FDA 510(k) clearance of the Root™ patient monitoring and connectivity platform that is destined to transform patient care throughout the hospital. High-impact innovati... More >>
Masimo Announces Support for the Every Newborn Action Plan to Reduce Global Newborn Mortality - 06/27/14
Masimo's iSpO2 Rx Mobile Pulse Oximetry Technology Ideal for Early Detection of Health Conditions in Newborns in Low-Resource Settings IRVINE, CA -- (Marketwired) -- 06/27/14 -- Masimo (NASDAQ: MASI) today announced its unconditional commitment to... More >>
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Masimo Corporation posts new information to the site. Just enter your e-mail address and click Submit.
 

To request a copy of the Annual Report, click here.

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.